Treatment Outcomes of Primary vs. Referred Patients with Multiple Myeloma Receiving Talquetamab or Teclistamab

被引：0
|
作者：
Fries, Gina [1 ]
Alshlah, Ali [1 ]
Baran, Andrea [1 ]
Lipe, Brea [2 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY USA
[2] UR Med, Dept Med, Rochester, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-119
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [31] Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: A retrospective medical records review
    Weide, Rudolf
    Koeppler, Hubert
    Antras, Lucia
    Smith, Michael
    Chang, Eva
    Green, Jesse
    Wintfeld, Neil
    Neary, Maureen P.
    Duh, Mei Sheng
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (01) : 31 - 35
  • [32] Teclistamab zur Therapie beim multiplen MyelomTeclistamab for the treatment of multiple myeloma
    Lilli Sophie Sester
    Hartmut Goldschmidt
    Sirka Nitschmann
    Die Innere Medizin, 2023, 64 : 214 - 216
  • [33] Dosing Patterns and Early Safety and Effectiveness Outcomes in Patients with Multiple Myeloma Treated with Teclistamab in the Community Setting
    Beer, Timothy C.
    Graf, Gloria H. J.
    Lin, Dee
    Fernandez, Mariana
    Doyle, Margaret
    Hester, Laura L.
    Wu, Bingcao
    Huo, Stephen
    BLOOD, 2024, 144 : 2398 - 2399
  • [34] NURSING CONSIDERATIONS FOR TALQUETAMAB DOSING IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Blazquez, Patricia
    Chari, Ajai
    Renaud, Thomas
    Tolbert, Jaszianne
    Gray, Kathleen
    Catamero, Donna
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [35] Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab
    Chari, Ajai
    Krishnan, Amrita
    Rasche, Leo
    Ye, Jing Christine
    Garfall, Alfred
    Popat, Rakesh
    Lipe, Brea
    Qin, Xiang
    Campagna, Michela
    Masterson, Tara
    Tomlinson, Chalmer
    Hilder, Brandi
    Tolbert, Jaszianne
    Renaud, Thomas
    Smit, M. Damiette
    Gray, Kathleen
    Kane, Colleen
    Heuck, Christoph
    van de Donk, Niels W. C. J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10): : 665 - +
  • [36] Complete Remission After Teclistamab Treatment in Multiple Myeloma: Case Report
    Haidar, Nour A.
    Salignon, Karine
    Jounblat, Youssef
    El Jbeili, Mira B.
    Vaillant, Willy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S538 - S539
  • [37] A Single-Center Retrospective Comparison of Post-Transplant Outcomes in Patients Receiving VRD Vs. VD Vs. RD As Initial Therapy Prior to ASCT for Newly Diagnosed Multiple Myeloma (MM)
    Nussbaum, Nathan C.
    Dougherty, Andrew
    Vogl, Dan T.
    Weiss, Brendan M.
    Porter, David L.
    Wileyto, E. Paul
    Cunningham, Kathleen
    Mangan, Patricia A.
    Shelly, Brenda K.
    DiFilippo, Heather
    Stadtmauer, Edward A.
    BLOOD, 2012, 120 (21)
  • [38] Oral Symptom Assessment Using Patient Reported Outcomes (PRO) for Relapsed Multiple Myeloma Patients Treated with Talquetamab
    Popat, Rakesh
    Greenwood, Alexandra
    Wilson, William
    Mactier, Catriona
    Cerner, Aviva
    Worthington, Sarah
    Russell, Jennifer
    Jenkins, Chloe
    Hughes, Daniel
    Boyle, Eileen
    McMillan, Annabel
    Yong, Kwee
    Lee, Lydia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S123 - S123
  • [39] Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience
    Lachenal, Florence
    Lebreton, Pierre
    Bouillie, Sylvie
    Matteo, Gian
    Aftisse, Hassina
    Pascal, Laurent
    Montes, Lydia
    Macro, Margaret
    Vignon, Marguerite
    Harel, Stephanie
    Fernandez, Mariana
    Louni, Chanaz
    Huart, Antoine
    Perrot, Aurore
    BLOOD, 2023, 142
  • [40] The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia
    Shrestha, Asis
    Thanendrarajan, Sharmilan
    Bag, Aishee
    Dhakal, Binod
    Zangari, Maurizio
    Al Hadidi, Samer
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Chakraborty, Rajshekhar
    Shah, Nishi
    Shah, Mansi R.
    Mohan, Meera
    Schinke, Carolina
    BLOOD, 2024, 144 : 6994 - 6995
12345